Get instant alerts when news breaks on your stocks. Claim your one week free trial for StreetInsider Premium here.
ROSELAND, NJ, April 14, 2022 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS)a leading developer of computerized drug delivery devices, which provide painless and precise injections, today announced that Arjan Haverhals, President and CEO of Milestone Scientific, will present at the eighteenth Noble Capital Markets’ annual investor conference to be held April 20-21, 2022 at the Hard Rock Hotel & Casino in Hollywood, Florida.
Mr. Haverhals will present Thursday, April 21 at 11:30 a.m. EST in the Seminole D Ballroom. Investors interested in meeting with management can meet in the breakout sessions on Wednesday, April 20 at 12 p.m. 3:00 p.m. Eastern Time at Table 10. and 3:15 p.m. Eastern Time at Table 6.
A high definition video webcast of the presentation will be available the following day on the Company’s website. https://www.milestonescientific.com/and as part of a comprehensive catalog of presentations available on the Noble Capital Markets conference website: www.nobleconference.com and on Channelcheck www.channelchek.com the investor portal created by Noble. The webcast will be archived on the company’s website, the NobleCon website and on Channelchek.com for 90 days following the event.
About Noble Capital Markets, Inc..Noble Capital Markets (“Noble”) is a research-driven investment bank that has been supporting small and micro cap stocks since 1984. As a FINRA and SEC-licensed broker-dealer, Noble provides equity research services for institutional quality, corporate and investment banking and order execution. . In 2005, Noble established NobleCon, an investor conference that has grown significantly over the past decade. Noble launched www.channelchek.com in 2018 – a community of investors dedicated exclusively to small and micro public companies and their industries. Channelchek is the first service to bring institutional quality research to the public, FREE at all levels without a subscription. More than 6,000 public emerging growth companies are listed on the site, with growing content including research, webcasts, podcasts and balanced news.
About Milestone Scientific Inc.Milestone Scientific Inc. (MLSS), a technology-driven medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise and efficient and to increase patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments provide the platform to advance the development of next-generation devices, regulating flow and monitoring pressure from the tip of the needle, through platform extensions. form of subcutaneous administration of drugs, including local anesthesia. To find out more, see the MLSS Brand Video or visit milestonescientific.com.
Safe Harbor StatementThis press release contains forward-looking statements regarding the timing and financial impact of Milestone’s ability to implement its business plan, expected revenues, timing of regulatory approvals and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments regarding future economic, competitive and market conditions, future business decisions and regulatory developments, all of which are difficult or impossible to predict with precision and many of which go beyond Milestone’s control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve anticipated revenue growth, changes in our operating expenses, decisions adverse patent, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and risk factors detailed from time to time in Milestone’s periodic filings with the Securities and Exchange Commission, including without limitation Milestone’s annual report for the year ended December 31, 2020. The forward-looking statements contained in this press release are based on management’s reasonable belief as of the date hereof. Milestone undertakes no obligation to publicly revise or update any forward-looking statements for any reason.
Contact: David Waldman or Natalya RudmanCrescendo Communications, LLCEmail: [email protected]Tel: 212-671-1020
Source: Milestone Scientific, Inc.